Inventor
QIU HAIBO
CN18 patents
⚠️ This page may combine multiple inventors who share the name “QIU HAIBO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
13 patentsUS11959897B2Apr 16, 2024
High confidence compound identification by liquid chromatography-mass spectrometry
REGENERON PHARMA1 citations70
US11371971B2Jun 28, 2022
High confidence compound identification by liquid chromatography-mass spectrometry
REGENERON PHARMA2 citations70
US11674968B2Jun 13, 2023
Methods for identifying free thiols in proteins
REGENERON PHARMA1 citations63
US12099042B2Sep 24, 2024
Use of liquid chromatography and mass spectrometry to characterize oligonucleotides
REGENERON PHARMA1 citations62
US12436152B2Oct 7, 2025
Methods for predicting and modulating glycation of a protein
REGENERON PHARMA0 citations60
US12259373B2Mar 25, 2025
High confidence compound identification by liquid chromatography-mass spectrometry
REGENERON PHARMA0 citations60
US12411141B2Sep 9, 2025
LC-MS methods for antibody isotyping and quantification
REGENERON PHARMA0 citations59
US12196761B2Jan 14, 2025
Use of LC-MS/MS to quantitate protein biomarkers
REGENERON PHARMA0 citations59
US12153053B2Nov 26, 2024
Unbiased and high-throughput identification and quantification of host cell protein impurities by automated iterative LC-MS/MS (HCP-AIMS) for therapeutic protein development
REGENERON PHARMA0 citations59
US11592449B2Feb 28, 2023
Use of LC-MS/MS to quantitate protein biomarkers
REGENERON PHARMA1 citations59
US12169199B2Dec 17, 2024
Activity based host cell protein profiling
REGENERON PHARMA0 citations56
US12169203B2Dec 17, 2024
Native microfluidic CE-MS analysis of antibody charge heterogeneity
REGENERON PHARMA0 citations51
US12172106B2Dec 24, 2024
Methods for assessing binding affinity of an antibody variant to the neonatal Fc receptor
REGENERON PHARMA0 citations48